ObsEva SA reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was USD 6.8 million compared to USD 44.6 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.54 a year ago.
ObsEva SA Swiss Exchange
Equities
OBSN
CH1260041939
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+18.95% | 2.6TCr | |
-23.86% | 1.94TCr | |
-19.03% | 1.59TCr | |
-20.90% | 1.51TCr | |
-46.14% | 1.51TCr | |
+63.85% | 1.49TCr | |
+4.49% | 1.39TCr |